Sign in

BINV on Nasdaq Stockholm AB

Bioinvent

Swedish clinical-stage biotech company

BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. The company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generatingnew drug candidates to fuel the Company’s own broad clinical development pipeline or for additional licensing and partnering. Currently, the company has five clinical programs for hematological cancer and solid tumor treatment.2 Its shares trade on Nasdaq Stockholm AB under the symbol BINV.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

See how the biggest companies compare on our leaderboards

BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. The company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generatingnew drug candidates to fuel the Company’s own broad clinical development pipeline or for additional licensing and partnering. Currently, the company has five clinical programs for hematological cancer and solid tumor treatment. Furthermore, the company has a fully integrated, proprietary, state-of-the art manufacturing facility unit. Martin Welschof has been CEO since 2018. The company is a partner of The Leukemia & Lymphoma Society’s Therapy Acceleration Program, an initiative that develops blood cancer treatment.2

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 42. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Benjamin Edwards Inc1,308,782$54.9M0.5%+5,583
Osaic Holdings, Inc.721,306$30.3M0.0%+236,704
Truist Financial Corp369,953$15.5M0.0%+340,042
Nvest Wealth Strategies, Inc.329,409$13.8M8.7%+16,130
Scotia Capital Inc.304,125$12.8M0.0%+2,685
Envestnet Asset Management Inc267,918$11.2M0.0%+166,496
Security National Bank256,388$10.8M1.3%+30,078
Stifel Financial Corp237,501$10.0M0.0%+73,541
Balance Wealth Partners LLC193,680$8.1M2.2%+11,805
Kelleher Financial Advisors191,105$8.0M1.1%New
Nuveen, LLC178,319$7.5M0.0%New
Jane Street Group, LLC153,070$6.4M0.0%−237,003
Evolve Private Wealth, LLC150,631$6.3M0.4%+4,737
LPL Financial LLC132,071$5.5M0.0%−5,016
Horizon Family Wealth, Inc.106,501$4.5M2.0%+7,419
Farther Finance Advisors, LLC102,531$4.3M0.0%New
Fjell Capital, LLC101,976$4.3M2.9%+19,678
Commonwealth Equity Services, LLC99,041$4.2M0.0%+20,732
Madison Asset Management, LLC85,134$3.6M0.0%+6,273
Rockefeller Capital Management L.P.80,936$3.4M0.0%+14,406
Ironsides Asset Advisors, LLC67,480$2.8M0.7%+6,803
Integrated Wealth Concepts LLC60,350$2.5M0.0%−974
Wealth Enhancement Advisory Services, LLC41,084$1.8M0.0%+5,608
Sanctuary Advisors, LLC35,170$1.5M0.0%+3,616
Susquehanna International Group, Llp32,918$1.4M0.0%−10,779

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2